State Board of Administration of Florida Retirement System’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-996
Closed -$27K 2356
2019
Q1
$27K Hold
996
﹤0.01% 2316
2018
Q4
$23K Hold
996
﹤0.01% 2333
2018
Q3
$55K Hold
996
﹤0.01% 2377
2018
Q2
$71K Hold
996
﹤0.01% 2375
2018
Q1
$61K Hold
996
﹤0.01% 2378
2017
Q4
$126K Hold
996
﹤0.01% 2332
2017
Q3
$136K Hold
996
﹤0.01% 2346
2017
Q2
$142K Buy
996
+10
+1% +$1.54K ﹤0.01% 2344
2017
Q1
$181K Hold
986
﹤0.01% 2236
2016
Q4
$79K Hold
986
﹤0.01% 2340
2016
Q3
$76K Hold
986
﹤0.01% 2346
2016
Q2
$85K Hold
986
﹤0.01% 2324
2016
Q1
$91K Hold
986
﹤0.01% 2344
2015
Q4
$198K Hold
986
﹤0.01% 2267
2015
Q3
$147K Buy
986
+8
+0.8% +$5.87K ﹤0.01% 2327
2015
Q2
$928K Buy
+978
New +$800K ﹤0.01% 1595

Other funds holding TTPH

State Board of Administration of Florida Retirement System's TTPH Position: Q2 2019 in Review

State Board of Administration of Florida Retirement System sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 996 shares — an estimated $27K sold.

State Board of Administration of Florida Retirement System first reported a position in TTPH in Q2 2015 and held it in 16 quarters. The position peaked at $928K in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • State Board of Administration of Florida Retirement System reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 996 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $27K.
  • State Board of Administration of Florida Retirement System first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
  • State Board of Administration of Florida Retirement System's Tetraphase Pharmaceuticals, Inc. position peaked at $928K in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2019, filed 5 Aug 2019.